Skip to content

Unlocking the self: Can microdosing psychedelics make one feel more authentic?

Ioana Pop, Jannis Dinkelacker

Nordisk alkohol- & narkotikatidskrift : NAT April 1, 2024 DOI: 10.1177/14550725231175353 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Sample size 18
Population Microdosers in the Netherlands
Intervention Microdosing
Duration 1 month
Topics Microdosing
Keywords Authenticity Experience sampling methods Psychedelics
Citations 5
Key findings State authenticity was significantly higher on microdosing days and the following day, and both the number of daily activities and satisfaction with them were positively related to state authenticity.

Abstract

Background and

Aim: In the present study, we focus on the relationship between state authenticity - the experience of being true to oneself in a particular moment - and microdosing - a practice that implies repeatedly ingesting very small doses of psychedelics that do not reach the threshold for perceptual alterations. We propose that microdosing could increase state authenticity through influencing people's mood and the number and satisfaction with daily activities.

Methods: We used self-assessments of state authenticity collected from 18 microdosers in the Netherlands across the period of 1 month for a total of 192 observations.

Results: We found that on the microdosing day and the day thereafter, state authenticity was significantly higher. Furthermore, the number of activities and the satisfaction with them were higher on the day when participants microdosed, while the following day only the number of activities was higher. Both the number or activities and the satisfaction with them were positively related to state authenticity.

Conclusion: We propose that feeling and behaving authentically could have a central role in explaining the positive effects of microdosing on health and wellbeing that are reported by current research.

Comparable studies

Other observational and cohort studies on microdosing, most cited first.

Study Year Design Participants
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers Respondents recruited from online forums 2019 Observational study
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing Individuals planning a weekly microdosing regimen 2021 Prospective observational study n = 81
Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration. More than a thousand individuals from 59 countries 2019 Observational cohort n = 1,000
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls Psilocybin microdosers and non-microdosing comparators 2022 Naturalistic observational study n = 1,133
Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study Healthy subjects 2011 Observational cohort

Citations in the library

Cited by 5

Cites 20

and 15 more in the library

Explore topics